早期直肠肿瘤:经肛内镜显微手术与内镜黏膜下剥离术的成本效果分析(MUCEM研究)
该非随机、两臂、多中心研究比较了内镜黏膜下剥离术(ESD)与经肛内镜显微手术(TEM)治疗早期直肠肿瘤的成本效果。共分析213例ESD和117例TEM,ESD在完全切除的增量净货币效益显著(€1797;95%CI €861-€3032;P<.001),且整块切除率更高、无病生存率更优,总体与严重并发症无显著差异。
要点
- ESD治疗早期直肠肿瘤比TEM更具成本效果,增量净货币效益显著。
- ESD整块切除率高于TEM(99.0% vs 92.5%,P<.01)。
- ESD无病生存率更高(94.3% vs 84.6%;调整HR 3.55;95%CI 1.64-7.75;P<.001)。
核心结论
- 对于早期直肠肿瘤,ESD比TEM更具成本效果,并提供更高质量的切除和更低的复发率。
研究设计与样本
- 非随机、两臂、比较性、多中心研究,同时进行成本效果分析。
- 主要纳入标准为可经ESD或TEM切除的早期直肠肿瘤(腺瘤、原位癌和usT1N0癌)。
- 主要有效性指标为完全切除;成本评估采用医疗系统视角和1年时间范围。
- 分析结果针对年龄、性别、体重指数、美国麻醉医师协会评分、组织学和既往盆腔手术等基线协变量进行调整。
主要发现
- 共分析213例ESD和117例TEM手术。
- 在1年时和2500欧元支付意愿下,ESD的增量净货币效益显著(€1797;95%CI €861-€3032;P<.001)。
- ESD在0至6000欧元的决策阈值范围内更具成本效果。
- 整块切除率有利于ESD(99.0% vs 92.5%,P<.01)。
- 总体和严重并发症发生率组间无显著差异。
临床怎么用
- 在早期直肠肿瘤的局部切除决策中,ESD可作为兼具成本效果和肿瘤学优势的选项。
局限性
- 研究为非随机设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: For the local excision of early rectal tumors (ERTs), the relative effectiveness of endoscopic submucosal dissection (ESD) vs transanal endoscopic microsurgery (TEM) is subject to debate. The comparisons are limited to retrospective, single-center studies lacking a health economic assessment. METHODS: A cost-effectiveness analysis was conducted alongside a nonrandomized, 2-arm, comparative, multicenter study. The main inclusion criterion was an ERT (adenomas, in situ and usT1N0 carcinomas) that could be resected with ESD or TEM, depending on the center. The primary effectiveness criterion was complete resection. A health care system perspective and a 1-year horizon were adopted for the cost evaluation. The results of the analysis were adjusted for baseline covariates: age, sex, body mass index, American Society of Anesthesiologists score, histology, and previous pelvic surgery. RESULTS: A total of 213 ESD and 117 TEM procedures were analyzed. At 1 year and with a willingness to pay of €2500 for complete resection, the incremental net monetary benefit of ESD was significant (€1797; 95% confidence interval, €861-€3,032; P < .001). ESD was more cost-effective for decision thresholds ranging from €0 to €6000. In terms of secondary outcomes, the en bloc excision rate favored ESD (99.0% vs 92.5%, P < .01). There were no significant between-group differences in overall and major morbidity. At 3 years, a cost-utility analysis did not reveal between-group differences in health-related quality of life, and the overall survival rates were similar. However, the disease-free survival rate was higher after ESD (94.3% vs 84.6% for TEM; adjusted hazard ratio, 3.55; 95% confidence interval, 1.64-7.75; P < .001). CONCLUSIONS: For ERT, ESD was more cost-effective and offered higher-quality excision and lower recurrence rates than TEM. (ClinicalTrials.gov, Number: NCT02885142).
引用
- Beyer-Berjot L, Delettrez C, Jacques J, et al. Transanal Endoscopic Microsurgery or Endoscopic Submucosal Dissection in Early Rectal Tumors: A Clinical and Cost-Effectiveness Analysis: The MUCEM Study. Gastroenterology. 2026. PMID: 41620037. doi:10.1053/j.gastro.2026.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。